Loading…
Medico Remedies (MEDICO)₹18.88−0.53%Pharmaceuticals
At the end of the Jun 2026 quarter, Medico Remedies' shareholders were: promoters 61.39%, FIIs 0.08%, public 38.53%. Promoter holding is unchanged on the quarter. FII holding is up 0.01 percentage points from 0.07% a year earlier. 0.00% of promoter shares were pledged. It had 15,862 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 73.35% | 73.35% | 73.35% | 73.35% | 73.35% | 66.84% | 63.80% | 62.60% | 61.39% | 61.39% | 61.39% | 61.39% |
| FIIs | 1.10% | 1.28% | 0.29% | 0.22% | 0.22% | 0.39% | 0.11% | 0.07% | 0.30% | 0.49% | 0.03% | 0.08% |
| DIIs | 0.00% | 0.00% | 0.74% | 0.97% | 0.97% | 0.78% | 0.01% | 0.01% | 0.01% | 0.00% | 0.00% | 0.00% |
| Public | 25.55% | 25.37% | 25.62% | 25.46% | 25.46% | 31.99% | 36.08% | 37.32% | 38.30% | 38.12% | 38.58% | 38.53% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 5,263 | 6,051 | 10,684 | 12,901 | 12,886 | 14,103 | 15,423 | 16,473 | 18,501 | 16,561 | 16,188 | 15,862 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Haresh Kapurlal Mehta | Promoter | 20.28% | 0.00 |
| Mehta Rishit Hareshbhai | Promoter | 12.60% | 0.00 |
| Harshit Haresh Mehta | Promoter | 10.33% | 0.00 |
| Rita H Mehta | Promoter | 8.09% | 0.00 |
| Ravi Goyal | Public | 6.80% | 0.00 |
| Shweta Harshit Mehta | Promoter | 5.90% | 0.00 |
| Priyal Rishit Mehta | Promoter | 4.16% | 0.00 |
| Metasoni Alloys Pvt Ltd | Public | Exited | — |
| Haresh K Mehta Huf | Promoter | 0.00% | 0.00 |
| Harshit H Mehta Huf | Promoter | 0.00% | 0.00 |
Promoters held 61.39% of Medico Remedies at the end of the Jun 2026 quarter, down 1.21 percentage points from 62.60% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.08% (up 0.05 percentage points from 0.03% a quarter earlier) and domestic institutions (DIIs) held 0.00% (unchanged at 0.00% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Medico Remedies had 15,862 shareholders at the end of the Jun 2026 quarter, against 16,473 a year earlier.
Ravi Goyal (Public) held 6.80% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.